- 全部删除
- 您的购物车当前为空
N-Acetylgalactosamine-6-Sulfatase (GALNS) 是一种在多种恶性肿瘤(如肺癌、乳腺癌、头颈癌等)中具有潜在通用生物标志物特性的酶。N-Acetylgalactosamine-6-Sulfatase 活性缺乏会导致 IVA 型黏多糖贮积病 (MPS IVA),亦称为 Morquio A 综合征。该酶可应用于 MPS IVA 与癌症的研究。
N-Acetylgalactosamine-6-Sulfatase (GALNS) 是一种在多种恶性肿瘤(如肺癌、乳腺癌、头颈癌等)中具有潜在通用生物标志物特性的酶。N-Acetylgalactosamine-6-Sulfatase 活性缺乏会导致 IVA 型黏多糖贮积病 (MPS IVA),亦称为 Morquio A 综合征。该酶可应用于 MPS IVA 与癌症的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
20 μg | 待询 | 待询 | |
100 μg | 待询 | 待询 | |
1 mg | 待询 | 待询 |
产品描述 | N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential universal biomarker for several malignant tumors, including lung cancer, breast cancer, and head and neck cancer. Insufficient activity of N-Acetylgalactosamine-6-Sulfatase can lead to mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. This enzyme is utilized in research related to MPS IVA and cancer. |
别名 | N-乙酰半乳糖胺-6-硫酸酯酶, N-Acetylgalactosamine-6-Sulfatase, GALNS, EC:3.1.6.4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
评论内容